NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas
Crossref DOI link: https://doi.org/10.1186/s12885-015-1806-8
Published Online: 2015-10-30
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Virani, Shama
Bellile, Emily
Bradford, Carol R.
Carey, Thomas E.
Chepeha, Douglas B.
Colacino, Justin A.
Helman, Joseph I.
McHugh, Jonathan B.
Peterson, Lisa A.
Sartor, Maureen A.
Taylor, Jeremy MG
Walline, Heather M.
Wolf, Greg T.
Rozek, Laura S.
License valid from 2015-10-30